BIOLIFE4D Seeks IPO For Artificial Heart Bioprinting Plans :

BIOLIFE4D has filed to raise $17 million in a U.S. IPO of stock and warrants. SAVU is still an early stage medical device company. Read about the IPO here.

Related Keywords

Steven Morris , Midwest Corporation , Market Research , Abiomed , Thoratec Corporation , D Corporation Financial Status , Aegis Capital Corp , D Corporation , Inland Midwest Corporation , Verified Market Research , Compound Annual Growth Rate , Corporation Financial , Statement Of Operations , Aegis Capital ,